Virginia A. Moyer, MD, MPH; on behalf of the U.S. Preventive Services Task Force*
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Financial Support: The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.
Potential Conflicts of Interest: None disclosed.
Requests for Single Reprints: Reprints are available from the USPSTF Web site (www.uspreventiveservicestaskforce.org).
Chinese translation
Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for HIV.
The USPSTF reviewed new evidence on the effectiveness of treatments in HIV-infected persons with CD4 counts greater than 0.200 × 109 cells/L; effects of screening, counseling, and antiretroviral therapy (ART) use on risky behaviors and HIV transmission risk; and long-term cardiovascular harms of ART.
These recommendations apply to adolescents, adults, and pregnant women.
The USPSTF recommends that clinicians screen adolescents and adults aged 15 to 65 years for HIV infection. Younger adolescents and older adults who are at increased risk should also be screened. (Grade A recommendation)
The USPSTF recommends that clinicians screen all pregnant women for HIV, including those who present in labor who are untested and whose HIV status is unknown. (Grade A recommendation)
Screening for HIV: clinical summary of U.S. Preventive Services Task Force recommendation.
Appendix Table 1. What the USPSTF Grades Mean and Suggestions for Practice
Appendix Table 2. USPSTF Levels of Certainty Regarding Net Benefit
Terms of Use
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Justin D. Lee, Daniel Arkfeld
USC Keck School of Medicine
August 8, 2013
Screening for HIV in a Conservative Environment
It is with much intererst that I have reviewed Dr. Moyer et. al. screening for HIV article. In this article it is recommended that HIV screening begins at fifteen and continues to sixty-five within the high risk population. Growing up in a conservative community, I have personal experience with several friends who should be screened due to potential high risk activity. However, this subject was taboo and not discussed. Through promotion of these guidelines, earlier diagnoses could be made which would help both the patient and our community. Now that I am applying soon for medical school, I will be dealing with this subject in my practice and it will be important to screen high risk patients across all demographics. In the future, it will be beneficial to communicate this study to the patients I will be seeing.
Moyer VA, on behalf of the U.S. Preventive Services Task Force*. Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013;159:51–60. doi: 10.7326/0003-4819-159-1-201307020-00645
Download citation file:
© 2018
Published: Ann Intern Med. 2013;159(1):51-60.
DOI: 10.7326/0003-4819-159-1-201307020-00645
Guidelines, HIV, Infectious Disease, Prevention/Screening.